Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Clinical Research on the Safety/Efficacy of Human Umbilical Cord Mesenchymal Stem Cell (19#iSCLife®-CSD) Therapy for Patients With Healing Poor After Uterus Injury

NCT03386708 is registered in ClinicalTrials.gov with Sclnow Biotechnology Co., Ltd. as lead sponsor.

NCT NCT03386708
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03386708 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Clinical Research on the Safety/Efficacy of Human Umbilical Cord Mesenchymal Stem Cell (19#iSCLife®-CSD) Therapy for Patients With Healing Poor After Uterus Injury
Lead sponsor
Sclnow Biotechnology Co., Ltd.
Phase
Phase 1
Overall status
Completed
Start date
October 1, 2018
Completion date
September 21, 2021
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

uterus; injury